Prior to joining the Institute for Molecular Bioscience, Dr Wyse was the Centre Manager at UQCCR, Faculty of Medicine. Dr Wyse developed his scientific knowledge and understanding of the scientific process through his PhD and post-doctoral positions both overseas (USA) and at UQ. He has authored numerous scientific papers, received grant funding, and is a named inventor on a product (Spinifex) that was sold to Novartis and reached Phase II clinical trials. Bruce’s management and governance experience has been garnered through research lab management and the responsibility of establishing a number of NATA accredited laboratories, namely ISO17025 and GLP at TetraQ (UQ) and ISO17025 and ISO15189 for the Australian Translational Genomics Centre (QUT).